Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.45 |
| ▸ | BDKRB2 | P30411 | 3/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19381802 | 1.00 | VHL (0.47) | VHLOPRD1OPRM1BDKRB2NTSR1 | |
| Rotigaptide SCHEMBL20547994 | 0.94 | VHL (0.49) | VHLOPRD1OPRM1BDKRB2 | |
| Rotigaptide SCHEMBL20547993 | 0.94 | VHL (0.49) | VHLOPRD1OPRM1BDKRB2 | |
| Rotigaptide SCHEMBL29359046 | 0.94 | VHL (0.49) | VHLOPRD1OPRM1BDKRB2 | |
| SCHEMBL20626228 | 0.87 | VHL (0.52) | VHLOPRD1OPRM1BDKRB2 | |
| SCHEMBL19381670 | 0.81 | VHL (0.52) | VHLOPRD1OPRM1 | |
| SCHEMBL29373528 | 0.81 | VHL (0.52) | VHLOPRD1OPRM1 | |
| SCHEMBL16925966 | 0.81 | VHL (0.52) | VHLOPRD1OPRM1 | |
| SCHEMBL31327461 | 0.80 | VHL (0.54) | VHLOPRD1OPRM1BDKRB2 | |
| SCHEMBL20782464 | 0.80 | F2 (0.37) | VHLOPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9764048-B2 | Targeted molecular imaging probe and method for in vivo molecular imaging | SHEN BAOZHONG (CN) | 2017-09-19 | — | — | US | disclosed |
| US-20150202335-A1 | TARGETED MOLECULAR IMAGING PROBE AND METHOD FOR IN VIVO MOLECULAR IMAGING | SHEN BAOZHONG (CN) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202335-A1 | TARGETED MOLECULAR IMAGING PROBE AND METHOD FOR IN VIVO MOLECULAR IMAGING | GJB2, GJA1, GAP43 | VHL 79/4885OPRD1 3801/4885OPRM1 3642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.